Abstract
In the present study, we have applied a novel strategy involving the postmortem measurement of the mitochondrial respiratory chain enzyme cytochrome-c oxidase (COX; complex IV) to identify regional changes in energy metabolism in the basal ganglia of chronic, medicated schizophrenics. COX activity was decreased in the caudate nucleus but increased in the putamen and nucleus accumbens. An increase in succinate dehydrogenase (complex II) was evident in the putamen and nucleus accumbens, but changes were not seen with NADH dehydrogenase (complex I). An analysis of interregional correlations in energy metabolism revealed several anomalies in the connections between the caudate and putamen and the globus pallidus in schizophrenics. Results provide strong evidence that changes in baseline energy metabolism in specific regions of the basal ganglia may exist in the disease. Based upon the high degree of input it receives from associative cortical areas, results suggest that a defect in the caudate may underlie certain aspects of cognitive decline in schizophrenics. In contrast, an increase in COX in the putamen, which receives extensive projections from the sensorimotor cortex, may reflect an effect of chronic neuroleptic treatment on motor function.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ackrell BA, Kearney EB, Singer TP . (1978): Mammalian succinate dehydrogenase. Methods Enzymol 53: 466–483
Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, Watkins GL, Hichwa RD . (1996): Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci U S A 93 (18): 9985–9990
Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD . (1997): Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349 (9067): 1730–1734
Beal MF . (1992): Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119–130
Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney WE . (1992): Fontostriatal disorder of cerbral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49: 935–942
Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JL, Manning RG, Flynn RW, Mann LS, Bunney WE Jr, Sokoloff L . (1982): Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 39: 251–259
Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, Kessler R . (1987): Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry 22 (4): 479–494
Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L, Gyllensten U . (1995): Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29: 217–224
Clark CM, Kessler R, Buchsbaum MS, Margolin RA, Holcomb HH . (1984): Correlational methods for determining regional coupling of cerebral glucose metabolism: A pilot study. Biol Psychiatry 19 (5): 663–678
Cleghorn JM, Garnett ES, Nahmias C, Firnau G, Brown GM, Kaplan R, Szechtman H, Szechtman B . (1989): Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res 28 (2): 119–133
DeLisi LE, Holcomb HH, Cohen RM, Pickar D, Carpenter W, Morihisa JM, King AC, Kessler R, Buchsbaum MS . (1985): Positron emission tomography in schizophrenic patients with and without neuroleptic medication. J Cereb Blood Flow Metab 5 (2): 201–206
Downs TR, Wilfinger WW . (1983): Fluorometric quantification of DNA in cells and tissue. Anal Biochem 131: 538–547
Early TS, Reiman EM, Raichle ME, Spitznagel EL . (1987): Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci U S A 84 (2): 561–563
Goldman-Rakic PS, Selemon LD . (1997): Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23 (3): 437–458
Hevner RF, Duff RS, Wong Riley MTT . (1992): Coordination of ATP production and consumption in brain: Parallel regulation of cytochrome oxidase and Na+,K+−ATPase. Neurosci Lett 138: 188–192
Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA . (1996): Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiat 153: 41–49
Katz M, Buchsbaum MS, Siegel BV Jr, Wu J, Haier RJ, Bunney WE Jr . (1996): Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 33 (1): 1–11
Kung L, Conley R, Chute DJ, Smialek J, Roberts RC . (1998): Synaptic changes in the striatum of schizophrenic cases: A controlled postmortem ultrastructural study. Synapse 28: 125–139.
Levy R, Friedman HR, Davachi L, Goldman-Rakic PS . (1997): Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J Neurosci 17 (10): 3870–3882
Markwell MAC, Maas SM, Biebar LL, Tolbert NE . (1978): A modification of the Lowry procedure to simplify protein determination in membrane and in protein samples. Anal Biochem 87: 206–211
Miller DD, Andreasen NC, O'Leary DS, Rezai K, Watkins GL, Ponto LL, Hichwa RD . (1997): Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology 17 (4): 230–240
Parent A . (1990): Extrinsic connections of the basal ganglia. Trends Neurosci 13: 254–258
Prince JA, Yassin MS, Oreland L . (1997a): Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharm Exp Ther 280: 261–267
Prince JA, Yassin MS, Oreland L . (1997b): A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics. Eur Neuropsychopharmacol 8: 1–6
Prince JA, Yassin M, Oreland L . (1997c): Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine. Neuropharmacology 36(11/12):1665–1678
Rago R, Mitchen J, Wilding G . (1990): DNA fluorometric assay in 96-well tissue culture plates using hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 191: 31–34
Shihabuddin L, Buchsbaum MS, Hazlett EA, Haznedar MM, Harvey PD, Newman A, Schnur DB, Spiegel-Cohen J, Wei T, Machac J, Knesaurek K, Vallabhajosula S, Biren MA, Ciaravolo TM, Luu-Hsia C . (1998): Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry 55: 235–243
Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG . (1993): Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 150 (9): 1325–1336
Singer VL, Jones LJ, Yue ST, Haugland RP . (1997): Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal Biochem 249 (2): 228–238
Tamminga CA, Thaker GK, Buchanen R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT . (1992): Limbic abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry 49: 522–530
Whitfield CD, Bostedor R, Goodrunt D, Haak N, Chu EHY . (1981): Hamster cell mutants unable to grow on galactose and exhibiting an overlapping complementation pattern are defective in the electron transport chain. J Biol Chem 256 (13): 6651–6656
Wiesel FA, Wik G, Sjogren I, Blomqvist G, Greitz T . (1987): Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients. Acta Psychiatr Scand 76 (6): 642–647
Wolkin A, Jaeger J, Brodic JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R . (1985): Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 142 (5): 564–571
Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, Cooper TB, Brodie JD, Laska E, Rotrose . (1996): Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 153 (3): 346–354
Wong-Riley M . (1979): Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 171: 11–28
Wong-Riley M . (1989): Cytochrome Oxidase: an endogenous metabolic marker for neuronal activity. TINS 12: 94–101
Wong-Riley M, Carrol EW . (1984): Effect of impulse blockage on cytochrome oxidase activity in monkey visual system. Nature 307: 262–264
Yonetani T, Ray G . (1965): Studies on cytochrome oxidase. J Biol Chem 240 (8): 3392–3399
Acknowledgements
This work was supported by grants from the Swedish Medical Research Council (Project No 4145), The Foundation for ‘Gamla Tjänarinnor’, and The Foundation for Psychiatric and Neurological Research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prince, J., Blennow, K., Gottfries, C. et al. Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic Schizophrenics. Neuropsychopharmacol 21, 372–379 (1999). https://doi.org/10.1016/S0893-133X(99)00016-0
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(99)00016-0
Keywords
This article is cited by
-
Effect of Novel Antipsychotics on Energy Metabolism — In Vitro Study in Pig Brain Mitochondria
Molecular Neurobiology (2021)
-
Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis
Journal of Bioenergetics and Biomembranes (2020)
-
Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease
Neuropsychopharmacology (2019)
-
Comparative Pharmacology of Risperidone and Paliperidone
Drugs in R&D (2015)
-
Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia
Metabolic Brain Disease (2015)
